Latest Form 4 insider transactions

NASDAQ
Marc D Beer, Executive Chairman and a Director of biote Corp., purchased 131,950 shares of common stock on August 10, 2026.
NYSE
Olin Corporation is reminding shareholders to vote on the proposed merger with Huntsman Corporation ahead of the August 25, 2026 special meeting.
NYSE
Olin Corporation is reminding shareholders to vote on the proposed merger with Huntsman Corporation ahead of the August 25, 2026 special meeting.
NAS
Angel Oak Strategic Credit Fund has filed a registration statement and post-effective amendment for its continuous offering of shares, detailing investment strategies, fees, and risks associated with its credit-focused interval fund structure.
NASDAQ
Anthony Ping Yeow Tan, Chief Executive Officer and a Director of Grab Holdings Ltd, sold 400,000 shares of common stock on August 10, 2026 for $3.62 per share.
NASDAQ
Jason Beesley, Chief Financial Officer of Pattern Group Inc., received 100,000 shares of common stock on August 11, 2026.
NYSE
Kimberly Anne Rutledge, Chief People Officer of Q2 Holdings, Inc., sold 10,000 shares of common stock on August 10, 2026 for $63.07 per share.
NASDAQ
Sheri Louise Dodd, Chief Executive Officer and a Director of Tactile Systems Technology Inc, sold 10,978 shares of common stock on August 10, 2026 for $29.44 per share.
NASDAQ
Anna P Barnitz, a Director of Ohio Valley Banc Corp, purchased 34 shares of common stock on August 12, 2026 for $44.49 per share.
NASDAQ
Charles S. Fuchs, President, R&D of Erasca, Inc., received 1,300,000 shares of common stock on August 10, 2026.
NASDAQ
Vikas Choudhary, a Director of Everspin Technologies Inc, received 15,693 shares of common stock on August 10, 2026.
NASDAQ
Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 10, 2026.
NASDAQ
Rajiv Basu, a Director of James River Group Holdings, Ltd., received 18,632 shares of common stock on August 12, 2026.
NASDAQ
Ivan Hyep, Chief Financial Officer of Bicara Therapeutics Inc., sold 12,500 shares of common stock on August 10, 2026 for $27.97 per share.
NASDAQ
Claire Mazumdar, Chief Executive Officer and a Director of Bicara Therapeutics Inc., sold 10,000 shares of common stock on August 10, 2026 for $27.98 per share.
NASDAQ
James Lacamp, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.
NASDAQ
Ryan Cohlhepp, President and COO and a Director of Bicara Therapeutics Inc., sold 18,750 shares of common stock on August 10, 2026 for $27.98 per share.
NASDAQ
Natalya Leahy, CEO of Lindblad Expeditions Holdings, Inc., reported a transaction in 15,000 shares of common stock on July 17, 2026.
NYSE
William C Losch Iii, President of Live Oak Bancshares, Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
Peter Batushansky, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.
NYSE
Ernest S Rady, Executive Chairman, a Director and 10% owner of American Assets Trust, Inc., purchased 193,243 shares of common stock on August 10, 2026.
NYSE
Renato Derraik, Chief Info./Digital Off., Bank of Live Oak Bancshares, Inc., reported multiple transactions in common stock on August 10, 2026.
NYSE
Rachel Barthelemy Marcon, President, Doors of Owens Corning, received 6,501 shares of common stock on August 10, 2026.
NASDAQ
Kathryn Guarini, a Director of Regeneron Pharmaceuticals, Inc., sold 400 shares of common stock on August 10, 2026 for $800.00 per share.
NYSE
Jonathan Mark Collins, EVP & Chief Financial Officer of Owens Corning, received 19,504 shares of common stock on August 10, 2026.
OTC.Pink
Vireo Growth Inc. provides an update on its Agreement and Plan of Merger with Planet 13 Holdings Inc., detailing procedural filings and forward-looking statements.
OQX
Vireo Growth Inc. provides an update on its Agreement and Plan of Merger with Planet 13 Holdings Inc., detailing procedural filings and forward-looking statements.
NASDAQ
Justin L. Mennen, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.
NYSE
Robert Z Hensley, a Director of Community Healthcare Trust Inc, purchased 8,000 shares of common stock on August 11, 2026 for $15.21 per share.
NYSE
Yvonne Genovese, EVP, Bus. & Tech. Insights of Gartner Inc, sold 1,205 shares of common stock on August 10, 2026 for $190.06 per share.